Skip NavigationSkip to Content

Imidazo[2,1-b]thiazole guanylhydrazones as RSK2 inhibitors [1]

  1. Author:
    Andreani, A.
    Granaiola, M.
    Leoni, A.
    Locatelli, A.
    Morigi, R.
    Rambaldi, M.
    Varoli, L.
    Lannigan, D.
    Smith, J.
    Scudiero, D.
    Kondapaka, S.
    Shoemaker, R. H.
  2. Author Address

    [Andreani, A; Granaiola, M; Leoni, A; Locatelli, A; Morigi, R; Rambaldi, M; Varoli, L] Univ Bologna, Dipartimento Sci Farmaceut, I-40126 Bologna, Italy. [Lannigan, D] Univ Virginia, Dept Microbiol, Ctr Cell Signaling, Charlottesville, VA 22908 USA. [Smith, J] Univ Virginia, Dept Pathol, Ctr Cell Signaling, Charlottesville, VA 22908 USA. [Scudiero, D] NCI, SAIC Frederick, Frederick, MD 21702 USA. [Kondapaka, S; Shoemaker, RH] NCI, Screening Technol Branch, Dev Therapeut Program, Div Canc Treatment & Diag, Frederick, MD 21702 USA.;Andreani, A (reprint author), Univ Bologna, Dipartimento Sci Farmaceut, Via Belmeloro 6, I-40126 Bologna, Italy;aldo.andreani@unibo.it shoemakr@mail.nih.gov
    1. Year: 2011
    2. Date: Sep
  1. Journal: European Journal of Medicinal Chemistry
    1. 46
    2. 9
    3. Pages: 4311-4323
  2. Type of Article: Article
  3. ISSN: 0223-5234
  1. Abstract:

    The activity of a series of imidazo[2,1-b]thiazole guanylhydrazones as inhibitors of p90 ribosomal S6 kinase 2 (RSK2) is described. It was found that a small subset of compounds show both potent inhibition of RSK2 kinase activity and tumor cell growth in vitro. Detailed study of one of the most active compounds indicates a high degree of selectivity for inhibition of RSK2 compared to a spectrum of other related kinases. Selective inhibition of the MCF-7 breast tumor cell line compared to MCF-10A non-transformed cells, as well as selective inhibition of the biomarker GSK3 provides evidence that the compounds can affect the RSK2 target in cells. (C) 2011 Elsevier Masson SAS. All rights reserved.

    See More

External Sources

  1. DOI: 10.1016/j.ejmech.2011.07.001
  2. WOS: 000295237400084

Library Notes

  1. Fiscal Year: FY2011-2012
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel